Emerson Y. Chen

1.6k total citations
47 papers, 844 citations indexed

About

Emerson Y. Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Emerson Y. Chen has authored 47 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 12 papers in Hepatology. Recurrent topics in Emerson Y. Chen's work include Colorectal Cancer Treatments and Studies (11 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Gastric Cancer Management and Outcomes (10 papers). Emerson Y. Chen is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Gastric Cancer Management and Outcomes (10 papers). Emerson Y. Chen collaborates with scholars based in United States, China and Switzerland. Emerson Y. Chen's co-authors include Vinay Prasad, John Marquart, Vikram Raghunathan, Alyson Haslam, Audrey Tran, Sunil K. Joshi, Charles D. Lopez, Adel Kardosh, Amit G. Singal and Adam C. Yopp and has published in prestigious journals such as Hepatology, Cancer and European Journal of Cancer.

In The Last Decade

Emerson Y. Chen

45 papers receiving 817 citations

Peers

Emerson Y. Chen
Artur Katz Brazil
William F. Pierce United States
Samuel Wagner United States
Meredith K. Chuk United States
C.J. Twelves United Kingdom
Alan Rong United States
Nan Soon Wong Singapore
Artur Katz Brazil
Emerson Y. Chen
Citations per year, relative to Emerson Y. Chen Emerson Y. Chen (= 1×) peers Artur Katz

Countries citing papers authored by Emerson Y. Chen

Since Specialization
Citations

This map shows the geographic impact of Emerson Y. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emerson Y. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emerson Y. Chen more than expected).

Fields of papers citing papers by Emerson Y. Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emerson Y. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emerson Y. Chen. The network helps show where Emerson Y. Chen may publish in the future.

Co-authorship network of co-authors of Emerson Y. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Emerson Y. Chen. A scholar is included among the top collaborators of Emerson Y. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emerson Y. Chen. Emerson Y. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rivero, Jaydira Del, et al.. (2024). Gastroenteropancreatic neuroendocrine tumors: Epigenetic landscape and clinical implications. Current Problems in Cancer. 52. 101131–101131. 1 indexed citations
4.
Kardosh, Adel, Robert Eil, Emerson Y. Chen, et al.. (2024). A Modified Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion. Annals of Surgical Oncology. 31(10). 6537–6545. 3 indexed citations
6.
Chen, Emerson Y., Adel Kardosh, Nima Nabavizadeh, et al.. (2023). Phase 2 study of preoperative chemotherapy with nab‐paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node‐positive pancreatic ductal adenocarcinoma. Cancer Medicine. 12(12). 12986–12995. 3 indexed citations
7.
Thawani, Rajat, et al.. (2023). Estimating the Time Toxicity of Contemporary Systemic Treatment Regimens for Advanced Esophageal and Gastric Cancers. Cancers. 15(23). 5677–5677. 8 indexed citations
8.
Zhang, Xuan, Tao Wu, Pin Gao, et al.. (2022). Rectal gastrointestinal stromal tumor with metachronous liver metastasis demonstrated no relapse after multidisciplinary team discussion and comprehensive treatment: a case report. Journal of Gastrointestinal Oncology. 13(5). 2679–2688. 2 indexed citations
9.
Prasad, Vinay, Timothée Olivier, Emerson Y. Chen, & Alyson Haslam. (2022). Estimation of time cost of anti-cancer drugs approved based on comparisons to best supportive care: A cross sectional analysis. Journal of Cancer Policy. 34. 100363–100363. 9 indexed citations
10.
Thawani, Rajat, et al.. (2022). Comparison of neoadjuvant regimens for resectable gastroesophageal junction cancer: a systematic review of randomized clinical trials across three decades. Journal of Gastrointestinal Oncology. 13(3). 1454–1466. 4 indexed citations
11.
Sutton, Thomas L., Brett S. Walker, Elizabeth N. Dewey, et al.. (2022). Hepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: A propensity-matched analysis. Surgery. 173(6). 1314–1321. 12 indexed citations
12.
Eng, Cathy, Emerson Y. Chen, Jane E. Rogers, et al.. (2021). Moving Beyond the Momentum: Innovative Approaches to Clinical Trial Implementation. JCO Oncology Practice. 17(10). 607–614. 6 indexed citations
13.
Sutton, Thomas L., Brett S. Walker, Nima Nabavizadeh, et al.. (2021). Geographic Disparities in Referral Rates and Oncologic Outcomes of Intrahepatic Cholangiocarcinoma: A Population-Based Study. Annals of Surgical Oncology. 28(13). 8152–8159. 11 indexed citations
14.
Sutton, Thomas L., Brett S. Walker, Charles D. Lopez, et al.. (2021). Surgical and oncologic outcomes following repeat hepatic resection of colorectal liver metastasis: Who benefits?. The American Journal of Surgery. 221(6). 1114–1118. 11 indexed citations
15.
Walker, Brett S., Thomas L. Sutton, Luai Zarour, et al.. (2021). Circulating Hybrid Cells: A Novel Liquid Biomarker of Treatment Response in Gastrointestinal Cancers. Annals of Surgical Oncology. 28(13). 8567–8578. 16 indexed citations
16.
Chen, Emerson Y., Gina M. Vaccaro, John M. Strother, et al.. (2018). A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer. Anticancer Research. 39(1). 245–252. 3 indexed citations
17.
Chen, Emerson Y., et al.. (2018). Colorectal Cancer-Associated Spontaneous Tumor Lysis Syndrome: a Case Report and Review of the Current Literature. Journal of Gastrointestinal Cancer. 50(3). 668–673. 6 indexed citations
18.
Yarchoan, Mark, Changqing Ma, Andrea B. Troxel, et al.. (2016). pAKT Expression and Response to Sorafenib in Differentiated Thyroid Cancer. Hormones and Cancer. 7(3). 188–195. 11 indexed citations
19.
Singal, Amit G., Akbar K. Waljee, Nishant Patel, et al.. (2013). Therapeutic Delays Lead to Worse Survival Among Patients With Hepatocellular Carcinoma. Journal of the National Comprehensive Cancer Network. 11(9). 1101–1108. 64 indexed citations
20.
Chen, Emerson Y., Seth N. Sclair, Frank Czul, et al.. (2013). A Small Percentage of Patients With Hepatitis C Receive Triple Therapy With Boceprevir or Telaprevir. Clinical Gastroenterology and Hepatology. 11(8). 1014–1020.e2. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026